Dr. Craig M. Coopersmith

MD, FACS, FCCM
Especialidad: Surgical Critical Care
País: USA

An eminent academic surgeon in the area of surgical critical care, Dr. Coopersmith is one of the top national investigators of sepsis and shock.

Professor, Department of Surgery

Emory University School of Medicine

Director

Emory Critical Care Center

Vice Chair of Research, Department of Surgery

Emory University School of Medicine

Program Director, Surgical Critical Care Fellowship, Department of Surgery

Emory University School of Medicine

Director, Surgical/Transplant Intensive Care Unit

Emory University Hospital

Research Program

Cancer Immunology

Biography

Craig M. Coopersmith, MD, FACS, FCCM, is professor and vice chair of research in the Department of Surgery at Emory University School of Medicine. Dr. Coopersmith serves as director of the Emory Critical Care Center, a national leader in designing, testing, and implementing innovations in critical care. A board certified surgeon, he specializes in surgical critical care, and in the surgical treatment of sepsis and multiple organ failure.

Dr. Coopersmith is a member of the Cancer Immunology research program at Winship Cancer Institute. He is a Fellow of the American College of Surgeons and the American Surgical Association. He has served as president of the Society of Critical Care Medicine, and is a member of the American Society for Clinical Investigation. In 2020, he was inducted as a Master of Critical Care Medicine of the American College of Critical Care Medicine.

Education

Dr. Coopersmith received his MD from University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania. He completed his General Surgery Residency, Research Fellowship and Surgical Critical Care Fellowship at Barnes-Jewish Hospital, Washington University School of Medicine in St. Louis, Missouri.

Research

Dr. Coopersmith’s laboratory studies multiple facets of sepsis. One facet of special interest is cancer and sepsis, in light of the fact that cancer patients are significantly more likely to die of sepsis than non-cancer patients and the fact that sepsis is the most common reason for intensive care unit admission for patients with cancer. His lab is funded by the National Institutes of Health to study this in a grant titled, “The Impact of Cancer on the Pathophysiology of Sepsis.”

Publications

Dr. Coopersmith serves on the editorial board of Journal of the American College of Surgeons among several others, and has published numerous journal articles.